Spumigin 654
| Internal ID | cb3c87c5-4b2b-47c7-8387-2f697e5dff69 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | 2-[[1-[2-[[2-acetyloxy-3-(4-hydroxyphenyl)propanoyl]amino]-4-(4-hydroxyphenyl)butanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C32H42N6O9/c1-19(39)47-27(18-21-8-13-23(41)14-9-21)29(43)36-24(15-10-20-6-11-22(40)12-7-20)30(44)38-17-3-5-26(38)28(42)37-25(31(45)46)4-2-16-35-32(33)34/h6-9,11-14,24-27,40-41H,2-5,10,15-18H2,1H3,(H,36,43)(H,37,42)(H,45,46)(H4,33,34,35) |
| InChI Key | PAHUSUOEHURDBG-UHFFFAOYSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C32H42N6O9 |
| Molecular Weight | 654.70 g/mol |
| Exact Mass | 654.30132694 g/mol |
| Topological Polar Surface Area (TPSA) | 247.00 Ų |
| XlogP | 1.30 |
| Atomic LogP (AlogP) | 0.30 |
| H-Bond Acceptor | 9 |
| H-Bond Donor | 7 |
| Rotatable Bonds | 16 |
| 2-[[1-[2-[[2-acetyloxy-3-(4-hydroxyphenyl)propanoyl]amino]-4-(4-hydroxyphenyl)butanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid |
| 2-(((1-(2-((2-(acetyloxy)-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino)-4-(4-hydroxyphenyl)butanoyl)pyrrolidin-2-yl)(hydroxy)methylidene)amino)-5-carbamimidamidopentanoate |
| 2-((1-(2-((2-acetyloxy-3-(4-hydroxyphenyl)propanoyl)amino)-4-(4-hydroxyphenyl)butanoyl)pyrrolidine-2-carbonyl)amino)-5-(diaminomethylideneamino)pentanoic acid |
| 2-({[1-(2-{[2-(acetyloxy)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-(4-hydroxyphenyl)butanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-5-carbamimidamidopentanoate |
| RefChem:185067 |
| SPU 654 |
| (2-(2-acetoxy-3-(4-hydroxyphenyl)propanamido)-4-(4-hydroxyphenyl)butanoyl)prolylarginine |
| CHEBI:221536 |
| DTXSID901047397 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5000 | 50.00% |
| Caco-2 | - | 0.8935 | 89.35% |
| Blood Brain Barrier | - | 0.7000 | 70.00% |
| Human oral bioavailability | - | 0.8429 | 84.29% |
| Subcellular localzation | Mitochondria | 0.7277 | 72.77% |
| OATP2B1 inhibitior | - | 0.7112 | 71.12% |
| OATP1B1 inhibitior | + | 0.8822 | 88.22% |
| OATP1B3 inhibitior | + | 0.9374 | 93.74% |
| MATE1 inhibitior | - | 0.7400 | 74.00% |
| OCT2 inhibitior | - | 0.6250 | 62.50% |
| BSEP inhibitior | + | 0.8694 | 86.94% |
| P-glycoprotein inhibitior | + | 0.7740 | 77.40% |
| P-glycoprotein substrate | + | 0.8066 | 80.66% |
| CYP3A4 substrate | + | 0.7260 | 72.60% |
| CYP2C9 substrate | - | 0.8042 | 80.42% |
| CYP2D6 substrate | - | 0.8431 | 84.31% |
| CYP3A4 inhibition | - | 0.6968 | 69.68% |
| CYP2C9 inhibition | - | 0.7812 | 78.12% |
| CYP2C19 inhibition | - | 0.7593 | 75.93% |
| CYP2D6 inhibition | - | 0.9228 | 92.28% |
| CYP1A2 inhibition | - | 0.8956 | 89.56% |
| CYP2C8 inhibition | - | 0.5628 | 56.28% |
| CYP inhibitory promiscuity | - | 0.9038 | 90.38% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.5948 | 59.48% |
| Eye corrosion | - | 0.9897 | 98.97% |
| Eye irritation | - | 0.9353 | 93.53% |
| Skin irritation | - | 0.7710 | 77.10% |
| Skin corrosion | - | 0.9328 | 93.28% |
| Ames mutagenesis | - | 0.5700 | 57.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3695 | 36.95% |
| Micronuclear | + | 0.7900 | 79.00% |
| Hepatotoxicity | - | 0.5199 | 51.99% |
| skin sensitisation | - | 0.8776 | 87.76% |
| Respiratory toxicity | + | 0.8333 | 83.33% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.9125 | 91.25% |
| Nephrotoxicity | - | 0.6006 | 60.06% |
| Acute Oral Toxicity (c) | III | 0.6615 | 66.15% |
| Estrogen receptor binding | + | 0.7765 | 77.65% |
| Androgen receptor binding | + | 0.7431 | 74.31% |
| Thyroid receptor binding | + | 0.5688 | 56.88% |
| Glucocorticoid receptor binding | + | 0.6453 | 64.53% |
| Aromatase binding | + | 0.5326 | 53.26% |
| PPAR gamma | + | 0.7425 | 74.25% |
| Honey bee toxicity | - | 0.7731 | 77.31% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.5700 | 57.00% |
| Fish aquatic toxicity | + | 0.8528 | 85.28% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.64% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.22% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.19% | 94.45% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 97.73% | 100.00% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 96.61% | 93.10% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 96.47% | 98.33% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 96.03% | 96.67% |
| CHEMBL3837 | P07711 | Cathepsin L | 95.93% | 96.61% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.43% | 99.17% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 95.38% | 95.17% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 94.43% | 95.89% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 93.64% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.59% | 93.56% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 93.06% | 82.69% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.01% | 91.11% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 92.68% | 95.89% |
| CHEMBL233 | P35372 | Mu opioid receptor | 91.68% | 97.93% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 91.60% | 95.52% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.10% | 97.09% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 90.93% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 90.64% | 91.19% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 90.30% | 90.71% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 89.86% | 97.64% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 89.86% | 98.24% |
| CHEMBL1808 | P12821 | Angiotensin-converting enzyme | 89.77% | 93.39% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 89.36% | 98.10% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 89.16% | 90.20% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.85% | 100.00% |
| CHEMBL204 | P00734 | Thrombin | 88.61% | 96.01% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 87.09% | 97.21% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 87.00% | 100.00% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 86.01% | 96.03% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 85.48% | 91.81% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 85.47% | 95.56% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 84.67% | 96.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 84.58% | 96.67% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 84.44% | 82.86% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.75% | 93.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 83.67% | 99.35% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 83.33% | 85.00% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 83.26% | 99.17% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 83.13% | 94.00% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 80.14% | 94.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146684834 |
| LOTUS | LTS0107115 |
| wikiData | Q104246309 |